![David Soergel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Soergel
Hoofd Techniek/Wetenschap/O&O bij
MADRIGAL PHARMACEUTICALS, INC.
Vermogen: 5 M $ op 30-09-2026
Profiel
David Soergel is Chief Medical Officer & Executive Vice President at Madrigal Pharmaceuticals, Inc. since 2025.
Formerly, Dr. Soergel was Senior Director-Clinical Development at Concert Pharmaceuticals, Inc., Director-Discovery Medicine at GlaxoSmithKline LLC, and Chief Medical Officer at Trevena, Inc. in 2015.
Education includes undergraduate studies at The Johns Hopkins University and a doctorate from Cornell University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-06-2026 | 10.033 ( 0,04% ) | 5 M $ | 30-09-2026 |
Actieve functies van David Soergel
| Bedrijven | Functie | Begin |
|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 21-04-2025 |
Eerdere bekende functies van David Soergel
| Bedrijven | Functie | Einde |
|---|---|---|
| CONCERT PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Corporate Officer/Principal | - |
| TREVENA, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van David Soergel
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
27
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Concert Pharmaceuticals, Inc.
 Concert Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel medicines | Health Technology |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trevena, Inc.
 Trevena, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on the development and commercialization of novel medicines for patients affected by central nervous system | Health Technology |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Madrigal Pharmaceuticals, Inc.
 Madrigal Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small-molecule drugs for cardiovascular, metabolic and liver diseases | Health Technology |
